Redhill Biopharma Ltd. (RDHL) Financials
RDHL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-06-30 | 35.0 million | 31.6 million |
2023-03-31 | 158.9 million | 207.3 million |
2022-12-31 | 158.9 million | 207.3 million |
2022-09-30 | 157.2 million | 203.2 million |
RDHL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-06-30 | -10.6 million | 705000 |
2023-03-31 | -2.4 million | 1.1 million |
2022-12-31 | -2.4 million | 1.1 million |
2022-09-30 | -6.1 million | 1.6 million |
RDHL Net Income
No data available :(
RDHL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-06-30 | 7.0 million | - | 2.3 million |
2023-03-31 | 20.0 million | - | 7.0 million |
2022-12-31 | 20.0 million | - | 7.5 million |
2022-09-30 | 15.2 million | - | 7.0 million |
RDHL Shares Outstanding
RDHL Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-06-30 | 7000 | 1.2 million | 3.5 million | 4.5 million |
2023-03-31 | 1335 | 1.1 million | 32.9 million | -19.9 million |
2022-12-31 | - | 1.1 million | 32.9 million | 19.9 million |
2022-09-30 | 22000 | 1.6 million | 6.5 million | 7.1 million |
RDHL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-06-30 | 1.8 million | 806000 |
2023-03-31 | 12.8 million | 8.6 million |
2022-12-31 | 12.8 million | 8.6 million |
2022-09-30 | 17.6 million | 9.5 million |
RDHL
Price: $0.46
52 week price:
Earnings Per Share: 4.00 USD
P/E Ratio: -0.07
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 100.7 million
Ebitda: -13.8 millionMarket Capitalization: 14.4 million